Our Story
Our Labs
Oncology
Immunology
Pharmacokinetics
SELEX
Our News
Join Us
中文版
English
ES
pmglobal@precedo.cn
Company News
Jul 28,2022
Ba/F3 cells facilitate the development of anti-tumor targeted drugs
More than 500 kinases are encoded in the human genome, which regulate up to one-third of the human proteome through post-translational phosphorylation of proteins, providing multiple nodes for therapeutic intervention in many abnormal biological processes.
Jan 10,2022
Zhongke Prisheng creates a new model of service-oriented biobank!
Recently, we participated in the 25th Annual Meeting of the International Association of Biological and Environmental Sample Banks (ISBER) in Melbourne, and discussed the development of the sample bank in the next 25 years with more than 30 national sample banks (biobanker), of which "Service Biobanks" has become one of the main direction markers. The three service platforms of the renewable tumor primary cell Biobank were recognized by the experts at the meeting. Zhongke Prerise sample database will explore new mechanisms for joint development with international and domestic tumor-related sample databases to provide new personalized services for clinical patients and pharmaceutical companies.
Nov 12,2021
Copleuerisheng VAV1 target one-stop solution to solve the research and development difficulties
Guanine nucleotide exchange factor (GEF) VAV1 is mainly expressed in human hematopoietic cells, including T and B cells, monocytes, natural killer (NK) cells, granulocytes, and dendritic cells. VAV1 activation is influenced by multiple upstream PTK and scaffold proteins and complex phosphorylation kinetics involving multiple tyrosine residues on different VAV1 domains
Zhongkopresen assists in preclinical pharmacokinetic (PK) research
Pharmacokinetics is the application of mathematical processing methods to quantitatively describe the dynamic changes of drugs and other exogenous substances in the body, and study the body's treatment of drug absorption, distribution, metabolism and excretion, as well as the resulting pharmacological and toxicological significance.
【 New express 】 -- "High-activity, customized" kinase protein series products are released today!
We provide high-purity, high-activity recombinant kinase protein products and recombinant protein customized expression and purification services. The kinase products have been optimized by the production system, self-developed and self-produced, and the quality of the whole process is strictly controlled.
